Here are four insights:
1. As president and COO, Mr. Blain will be responsible for product development, quality, marketing, operations and regulatory compliance.
2. Previously, Mr. Blain served as president and co-founder of Spinal Elements prior to Amendia’s acquisition of the company. The combined company was later renamed Spinal Elements.
3. With over 20 years of orthopedic experience, Mr. Blain has provided his expertise to Smith & Nephew, Alphatec and NuVasive throughout his career.
4. Spinal Elements designs, develops, manufactures and markets medical devices used in spinal surgeries. The company focuses on the development of medical device technologies, biologics and instrumentation.
More articles on devices and implants:
Orthopedic trauma devices market projects 7.2% CAGR: 6 takeaways
Providence Medical Technology reports outcomes from 2 studies on DTRAX Expandable Cage: 5 notes
InVivo Therapeutics welcomes Dr. Richard Toselli as CMO: 4 highlights
